SGH
TEVA icon

Schonfeld Group Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Schonfeld Group Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-8,200
Closed -$463K – 328
2015
Q3 		$463K Buy
+8,200
New +$532K 0.24% 76
2014
Q2 		– Sell
-16,400
Closed -$867K – 315
2014
Q1 		$867K Buy
+16,400
New +$758K 0.22% 123

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Schonfeld Group Holdings's TEVA Position: Q4 2015 in Review

Schonfeld Group Holdings sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 8,200 shares — an estimated $463K sold.

Schonfeld Group Holdings first reported a position in TEVA in Q1 2014 and held it in 2 quarters. The position peaked at $867K in Q1 2014. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

  • Schonfeld Group Holdings reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Schonfeld Group Holdings sold 8,200 Teva Pharmaceuticals shares in Q4 2015, an estimated $463K.
  • Schonfeld Group Holdings first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Schonfeld Group Holdings's Teva Pharmaceuticals position peaked at $867K in Q1 2014.
  • 876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.